How to Take Saccharomyces Boulardii With Antibiotics

Start taking Saccharomyces boulardii as soon as you begin your antibiotic course, ideally on the same day or within the first 48 hours. The typical dose is 250 to 500 mg once or twice daily, and you can swallow it at the same time as your antibiotic pill without worrying about one canceling the other out. That last point surprises many people, because conventional wisdom says probiotics and antibiotics should be separated by hours. But S. boulardii plays by different rules, and understanding why changes how you use it.

Why S. Boulardii Survives Antibiotics

Most probiotics are bacteria, which means they can be wiped out by the very antibiotics you are taking. S. boulardii is a yeast, a fundamentally different type of organism. Antibiotics target bacterial machinery, so they pass right over this yeast without harming it.¹ This is the single most important practical fact about S. boulardii: you do not need to time your doses hours apart from your antibiotic the way you might with a bacterial probiotic like Lactobacillus. You can take them together at the same meal, and the yeast will still be alive and active in your gut.

This also means there is no particular antibiotic class that renders S. boulardii useless. Whether you are on a penicillin derivative, a fluoroquinolone, a macrolide, or a cephalosporin, the yeast remains unaffected. That versatility is a large part of why it has become the most-studied probiotic for antibiotic-associated diarrhea.

When to Start and How Long to Continue

Timing matters more than most people realize, and earlier is better. Clinical evidence consistently points to initiating S. boulardii at the start of antibiotic treatment or within the first 48 hours for the best protective effect.² One large hospital-based study found that patients who received S. boulardii within 24 hours of starting their antibiotic had roughly half the risk of developing a hospital-acquired C. difficile infection compared to those who started the yeast later.³ The takeaway is simple: if you are going to take it, do not wait until diarrhea appears. Start on day one.

As for how long to continue, most clinical protocols run S. boulardii for the full duration of the antibiotic course and then for a few days to a couple of weeks afterward. The typical range is 7 to 14 days depending on the situation.⁴ If your antibiotic course runs longer than two weeks, it is reasonable to continue the yeast for the entire duration. Extending it a few days past your last antibiotic dose gives your gut flora a bit more time to stabilize while the yeast is still present.

Dose and How to Take It

The standard adult dose in most clinical trials is 250 to 500 mg taken once or twice daily.⁴ Products vary in how they label potency, with some listing colony-forming units (CFUs) and others listing milligrams. A common commercial capsule delivers about 250 mg per capsule, standardized to roughly 5 billion CFUs. Taking one capsule twice a day with meals is the most frequently studied regimen.

You can take S. boulardii with food or on an empty stomach. It survives gastric acid well, which is part of why it works as an oral probiotic. That said, most studies have participants take it with a meal for convenience. If a capsule is too large to swallow, some products come in sachets of powder that you can mix into water or soft food. Just avoid mixing it into anything extremely hot, since heat kills the yeast. Room temperature or cool liquids are fine.

Storage differs by formulation. Freeze-dried preparations, the most common type on store shelves, tend to hold up well at room temperature for weeks or months, but refrigeration extends their shelf life. Spray-dried versions lose viability somewhat faster.⁵ Check the label: if it says “refrigerate after opening,” follow it. If not, keeping it in a cool, dry place is generally fine.

How Well It Prevents Antibiotic-Associated Diarrhea

The evidence here is substantial. A large meta-analysis pooling data from over 4,700 patients across 21 trials found that S. boulardii cut the risk of antibiotic-associated diarrhea roughly in half, from about 19% in control groups down to about 8.5% in those taking the yeast. The effect held in both adults and children.⁶ A separate meta-analysis in adults found essentially the same result, with a risk reduction of about 53%.⁷

One recent hospital-based trial painted an even more dramatic picture. Among hospitalized patients receiving antibiotics, diarrhea developed in about 8% of those given S. boulardii compared to over 70% in the placebo group.⁸ That particular trial used patients on aggressive antibiotic regimens in a hospital setting, so the baseline diarrhea rate was unusually high, which amplifies the apparent benefit. But even in outpatient settings with milder antibiotics, the roughly 50% relative risk reduction holds up consistently.

In practical terms, for every 10 people taking S. boulardii alongside antibiotics, about one person who would have developed diarrhea will be spared it.⁶ That may sound modest in percentage terms, but antibiotic-associated diarrhea is common enough that it adds up to a lot of avoided misery.

Protection Against C. Difficile Infection

Clostridioides difficile is the infection people fear most during and after antibiotic use, and for good reason. It can cause severe diarrhea, colitis, and in vulnerable patients, life-threatening complications. S. boulardii appears to offer meaningful protection here as well, though the data are strongest in hospital settings where C. difficile risk is highest.

A large retrospective study of hospitalized patients on high-risk antibiotics found that those who also received S. boulardii had about 43% lower odds of developing a hospital-onset C. difficile infection. When the yeast was started within the first 24 hours of the antibiotic, the reduction was even larger, roughly 53%.³ For people who already have a C. difficile infection, adding S. boulardii to standard vancomycin treatment has been shown to dramatically lower recurrence rates, from about 13% down to under 2% in one randomized trial.⁹

Part of the mechanism involves a protease that S. boulardii secretes in the gut. This enzyme physically breaks down the toxin produced by C. difficile and blocks it from attaching to the intestinal lining. In laboratory studies, pretreatment with the protease reduced toxin binding by over 40% and cut the intestinal damage caused by the toxin significantly.¹⁰ It is worth noting that this is one of the rare cases in probiotic research where a specific molecular mechanism has been convincingly demonstrated, rather than just observing that the probiotic “works” without knowing why.

What It Does to Your Gut Microbiome

Beyond preventing diarrhea, S. boulardii appears to buffer the broader damage that antibiotics do to your gut ecosystem. Antibiotics tend to reduce the diversity of gut bacteria and allow certain opportunistic families to overgrow. In a controlled study, co-administering S. boulardii during antibiotic treatment preserved microbial diversity and suppressed the overgrowth of six bacterial families that antibiotics had promoted, including Enterobacteriaceae and Enterococcaceae, groups that contain many opportunistic pathogens. At the same time, the yeast boosted the abundance of beneficial families associated with gut health.¹¹

The picture that emerges from microbiome studies is that S. boulardii does not simply restore your pre-antibiotic gut flora. Instead, it creates what researchers describe as an alternative bacterial ecosystem, one that is more diverse and balanced than the disrupted state antibiotics leave behind, though not identical to your original baseline. Separate research using a model of the human gut confirmed that S. boulardii had a stimulating effect on the most abundant beneficial bacterial groups after antibiotic exposure.¹² These microbiome-level effects are likely a big part of why the yeast reduces diarrhea: by keeping the bacterial community more stable, it prevents the kind of chaotic overgrowth that leads to loose stools and GI distress.

Broad-Spectrum Antibiotics and Specific Combinations

Not all antibiotics carry the same diarrhea risk. Broad-spectrum drugs that hit a wide range of bacteria tend to cause the most gut disruption. Amoxicillin-clavulanate (sold as Augmentin in many countries) is a notorious offender, with diarrhea rates that can run as high as 20 to 30% in some populations. A randomized trial specifically looking at this combination found that adding S. boulardii blunted the microbiota shifts caused by amoxicillin-clavulanate, reduced the overgrowth of Escherichia species, and lowered diarrhea scores in healthy volunteers.¹³

If you have a history of getting diarrhea on antibiotics, you are a particularly good candidate for S. boulardii. The same goes if you have been prescribed a fluoroquinolone, a clindamycin course, or any extended antibiotic regimen, all of which carry elevated risks of gut disruption. The yeast is not a guarantee against GI side effects, but the evidence for benefit is strongest in exactly these higher-risk scenarios.

Using S. Boulardii During H. Pylori Treatment

Helicobacter pylori eradication therapy is one of the most side-effect-heavy antibiotic regimens patients commonly encounter. Triple therapy typically involves two antibiotics plus a proton pump inhibitor, taken for one to two weeks. Diarrhea, nausea, bloating, and constipation are frequent complaints. Adding S. boulardii to this regimen has been evaluated in multiple meta-analyses, and the results are consistently positive.

A recent meta-analysis of 19 studies including over 5,000 patients found that S. boulardii not only reduced the incidence of diarrhea by about 64% but also cut the rates of bloating, constipation, and nausea by roughly half compared to standard therapy alone. It also modestly improved the actual H. pylori eradication rate itself.¹⁴ An earlier meta-analysis found similar patterns, with overall side effects reduced by more than half and eradication rates ticking up.¹⁵ This is worth knowing if your doctor is about to put you on H. pylori therapy, since the side effects are a major reason people abandon treatment early, which leads to antibiotic resistance and treatment failure.

Who Should Not Take It

S. boulardii is remarkably safe for the general population, but there are specific groups who should avoid it entirely. Because it is a living yeast, it can in rare cases enter the bloodstream and cause a systemic fungal infection called fungemia. This risk is essentially limited to three categories of people:

Immunocompromised patients: People on immunosuppressive drugs, undergoing chemotherapy, or with conditions like advanced HIV should not take S. boulardii. Case reports have documented fungemia in immunosuppressed patients given the yeast orally, with molecular typing confirming the infection came from the probiotic capsule itself.¹⁶
Patients with central venous catheters: Yeast can colonize catheter lines. Even patients who are not immunosuppressed but have indwelling central lines are at elevated risk.
Critically ill patients or those with compromised gut integrity: People with severe pancreatitis, recent bowel surgery, or conditions that damage the intestinal barrier may allow the yeast to translocate from the gut into the blood.¹⁷ Published guidance states that S. boulardii should be considered carefully for any patient whose gastrointestinal tract integrity might be compromised.¹⁸

For otherwise healthy people taking an outpatient antibiotic course, fungemia from S. boulardii is extraordinarily rare. The case reports that exist almost always involve severely ill, hospitalized, immunocompromised individuals. Mild side effects like gas or mild bloating can occur in anyone but are uncommon and typically resolve quickly.

One interaction worth knowing about: antifungal medications like fluconazole will kill S. boulardii, since it is a yeast. If you happen to be taking a systemic antifungal at the same time as your antibiotic, the S. boulardii will not survive to do its job. In that scenario, a bacterial probiotic that is resistant to your specific antibiotic, if one exists, may be a better fit. Your pharmacist can help sort out whether your medication list is compatible.

Practical Checklist

Pulling together the evidence into something you can act on:

Start day one: Begin S. boulardii on the same day as your antibiotic, or within the first 48 hours at the latest.
Standard dose: 250 to 500 mg once or twice daily. One capsule twice a day with meals is the most common regimen in trials.
No spacing needed: Unlike bacterial probiotics, you do not need to separate S. boulardii from your antibiotic dose by two hours. Take them together if that is easiest.
Continue after finishing: Keep taking it for a few days to two weeks after your last antibiotic dose to support microbiome recovery.
Avoid heat: Do not dissolve powder or open capsules into hot drinks. Room temperature or cooler is fine.
Skip it if immunocompromised: If you are on immunosuppressants, have a central line, or have serious gut damage, talk to your doctor before using any live yeast probiotic.

How S. Boulardii Compares to Bacterial Probiotics During Antibiotic Use

People frequently ask whether S. boulardii is better than other probiotics for this purpose. The honest answer is that it has a structural advantage bacterial probiotics cannot match: antibiotic resistance by default. When you take a Lactobacillus or Bifidobacterium product alongside, say, amoxicillin, much of that bacterial probiotic may be killed before it reaches the colon. You can try to mitigate this by taking the bacterial probiotic hours apart from the antibiotic, but timing is imperfect and absorption varies. S. boulardii sidesteps the problem entirely.

That said, Lactobacillus rhamnosus GG is another probiotic with a reasonable evidence base for antibiotic-associated diarrhea. Some researchers have looked at combining both S. boulardii and L. rhamnosus GG for complementary effects on the microbiome.¹² There is no strong clinical trial evidence yet showing that the combination outperforms S. boulardii alone, but the rationale makes biological sense, since the two organisms occupy different niches and work through different mechanisms. If you decide to use both, the bacterial probiotic is the one that needs to be spaced away from your antibiotic dose, while the S. boulardii can be taken whenever is convenient.

1
PubMed Central. a href=”https://pmc.ncbi.nlm.nih.gov/articles/PMC10879266/” target=”_blank” rel=”noopener”>Can the Evidence-Based Use of Probiotics (Notably Saccharomyces boulardii CNCM I-745 and Lactobacillus rhamnosus GG) Mitigate the Clinical Effects of Antibiotic-Associated Dysbiosis?
2
PubMed Central. Can the Evidence-Based Use of Probiotics (Notably Saccharomyces boulardii CNCM I-745 and Lactobacillus rhamnosus GG) Mitigate the Clinical Effects of Antibiotic-Associated Dysbiosis?
3
PubMed. The Effect of Saccharomyces boulardii Primary Prevention on Risk of Hospital-onset Clostridioides difficile Infection in Hospitalized Patients Administered Antibiotics Frequently Associated With C. difficile Infection
4
PubMed Central. Probiotic paradox: Saccharomyces cerevisiae fungemia after S. boulardii use in severe pancreatitis
5
Preparative Biochemistry & Biotechnology. Preparation of Saccharomyces boulardii powder by spray drying: thermoprotectants optimization and stability evaluation
6
PubMed. Systematic review with meta-analysis: Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea
7
PubMed Central. Systematic review and meta-analysis of Saccharomyces boulardii in adult patients
8
Antibiotics. Saccharomyces boulardii for the Prevention of Antibiotic-Associated Diarrhea in Hospitalized Patients Receiving Antibiotics: A Single-Center, Randomized, Double-Blind, Placebo-Controlled Trial
9
Emerging Infectious Diseases. Efficacy and safety of Saccharomyces boulardii as adjunct therapy with Vancomycin in treating Clostridioides difficile infection: A randomized controlled trial
10
PubMed Central. Saccharomyces boulardii protease inhibits Clostridium difficile toxin A effects in the rat ileum
11
PubMed Central. Saccharomyces boulardii CNCM I-745 supplementation during and after antibiotic treatment positively influences the bacterial gut microbiota
12
PubMed. Lacticaseibacillus rhamnosus GG and Saccharomyces cerevisiae boulardii supplementation exert protective effects on human gut microbiome following antibiotic administration in vitro
13
PubMed Central. Prospective randomized controlled study on the effects of Saccharomyces boulardii CNCM I-745 and amoxicillin-clavulanate or the combination on the gut microbiota of healthy volunteers
14
PubMed Central. Efficacy and safety of Saccharomyces boulardii as an adjuvant therapy for the eradication of Helicobacter pylori: a meta-analysis
15
PubMed. Meta-analysis: the effects of Saccharomyces boulardii supplementation on Helicobacter pylori eradication rates and side effects during treatment
16
PubMed. Saccharomyces cerevisiae fungemia after Saccharomyces boulardii treatment in immunocompromised patients
17
PubMed Central. Saccharomyces boulardii fungemia caused by treatment with a probioticum
18
Emerging Infectious Diseases. Fungemia and Other Fungal Infections Associated with Use of Saccharomyces boulardii Probiotic Supplements